PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
27.11
+0.65 (2.46%)
May 28, 2026, 1:29 PM EDT - Market open
PROCEPT BioRobotics Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, PROCEPT BioRobotics stock has a consensus rating of "Buy" and an average price target of $30.44. The average 1-year stock price forecast is 12.28% higher than the current stock price, while the lowest is $20 (-26.23%) and the highest is $37 (+36.48%).
Price Target: $30.44 (+12.28%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PROCEPT BioRobotics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 6 | 6 | 6 | 6 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 2 | 3 | 3 | 4 | 4 | 4 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 13 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 14, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $34 | Buy | Reiterates | $34 | +25.41% | May 14, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Maintains $20 | Sell | Maintains | $20 | -26.23% | May 13, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Apr 30, 2026 |
| BTIG | BTIG | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Apr 30, 2026 |
Financial Forecast
Revenue This Year
406.88M
from 308.05M
Increased by 32.08%
Revenue Next Year
501.61M
from 406.88M
Increased by 23.28%
EPS This Year
-1.55
from -1.72
EPS Next Year
-0.94
from -1.55
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 423.4M | 527.6M | |||
| Avg | 406.9M | 501.6M | |||
| Low | 384.9M | 467.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 37.5% | 29.7% | |||
| Avg | 32.1% | 23.3% | |||
| Low | 25.0% | 14.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.43 | -0.59 | |||
| Avg | -1.55 | -0.94 | |||
| Low | -1.62 | -1.25 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.